Compare Indoco Remedies with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs REPCO HOME - Comparison Results

INDOCO REMEDIES     Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

REPCO HOME 
   Change

Repco Home Finance Ltd or RHFL is a professionally managed housing finance company headquartered in Chennai, Tamil Nadu. Incorporated in April 2000 as a wholly owned subsidiary of the Repatriates Co-operative Finance and Development Bank Limited (Rep... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES REPCO HOME INDOCO REMEDIES/
REPCO HOME
 
P/E (TTM) x 50.5 7.5 675.8% View Chart
P/BV x 2.0 1.3 151.3% View Chart
Dividend Yield % 0.7 0.8 88.7%  

Financials

 INDOCO REMEDIES   REPCO HOME
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-18
REPCO HOME
Mar-18
INDOCO REMEDIES/
REPCO HOME
5-Yr Chart
Click to enlarge
High Rs317923 34.4%   
Low Rs178515 34.6%   
Sales per share (Unadj.) Rs113.1176.7 64.0%  
Earnings per share (Unadj.) Rs4.532.9 13.6%  
Cash flow per share (Unadj.) Rs11.833.4 35.3%  
Dividends per share (Unadj.) Rs1.002.20 45.5%  
Dividend yield (eoy) %0.40.3 131.9%  
Book value per share (Unadj.) Rs73.2215.4 34.0%  
Shares outstanding (eoy) m92.1562.56 147.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.24.1 53.8%   
Avg P/E ratio x55.521.8 254.2%  
P/CF ratio (eoy) x21.021.5 97.5%  
Price / Book Value ratio x3.43.3 101.3%  
Dividend payout %22.46.7 335.3%   
Avg Mkt Cap Rs m22,83044,981 50.8%   
No. of employees `0005.50.8 694.9%   
Total wages/salary Rs m2,209488 453.0%   
Avg. sales/employee Rs Th1,910.114,081.9 13.6%   
Avg. wages/employee Rs Th405.0621.3 65.2%   
Avg. net profit/employee Rs Th75.52,625.7 2.9%   
INCOME DATA
Net Sales Rs m10,41911,054 94.3%  
Other income Rs m4723 203.9%   
Total revenues Rs m10,46611,077 94.5%   
Gross profit Rs m1,3499,634 14.0%  
Depreciation Rs m67731 2,191.3%   
Interest Rs m2356,484 3.6%   
Profit before tax Rs m4843,143 15.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m721,082 6.7%   
Profit after tax Rs m4122,061 20.0%  
Gross profit margin %12.987.2 14.9%  
Effective tax rate %15.034.4 43.5%   
Net profit margin %4.018.6 21.2%  
BALANCE SHEET DATA
Current assets Rs m5,3737,154 75.1%   
Current liabilities Rs m4,15732,950 12.6%   
Net working cap to sales %11.7-233.4 -5.0%  
Current ratio x1.30.2 595.3%  
Inventory Days Days680-  
Debtors Days Days730-  
Net fixed assets Rs m6,244135 4,626.7%   
Share capital Rs m184626 29.5%   
"Free" reserves Rs m6,56612,850 51.1%   
Net worth Rs m6,75013,476 50.1%   
Long term debt Rs m1,23350,901 2.4%   
Total assets Rs m12,36399,939 12.4%  
Interest coverage x3.11.5 206.0%   
Debt to equity ratio x0.23.8 4.8%  
Sales to assets ratio x0.80.1 762.0%   
Return on assets %5.28.5 61.2%  
Return on equity %6.115.3 39.9%  
Return on capital %9.015.0 60.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,7620-   
Fx outflow Rs m1,14328 4,054.6%   
Net fx Rs m2,619-28 -9,286.9%   
CASH FLOW
From Operations Rs m1,227-5,571 -22.0%  
From Investments Rs m-1,3604 -34,002.5%  
From Financial Activity Rs m-3885,615 -6.9%  
Net Cashflow Rs m-52149 -1,066.8%  

Share Holding

Indian Promoters % 59.2 37.3 158.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 12.5 16.5 75.8%  
FIIs % 6.0 30.1 19.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 16.2 138.3%  
Shareholders   12,805 12,020 106.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   ADANI PORTS & SEZ  BAJAJ FINANCE  TIMKEN INDIA  FINOLEX INDUSTRIES  S.P. APPARELS  



Today's Market

Sensex Ends 70 Points Higher; Telecom and Banking Stocks Advance(Closing)

Indian share markets traded on a positive note throughout the day and ended marginally higher. The BSE Sensex rose over 350 points intraday.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1% (Quarterly Result Update)

Nov 5, 2019 | Updated on Nov 5, 2019

For the quarter ended September 2019, INDOCO REMEDIES has posted a net profit of Rs 73 m (up 194.1% YoY). Sales on the other hand came in at Rs 3 bn (up 23.9% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

REPCO HOME Announces Quarterly Results (3QFY19); Net Profit Up 14.8% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, REPCO HOME has posted a net profit of Rs 556 m (up 14.8% YoY). Sales on the other hand came in at Rs 3 bn (up 9.5% YoY). Read on for a complete analysis of REPCO HOME's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Nov 15, 2019 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 5-YR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS